An Illinois court ordered pharmaceutical giant Johnson & Johnson and its former subsidiary Kenvue to pay $45 million to the family of Theresa Garcia, who alleged that the companies’ talcum-based baby powder products led to her death from mesothelioma. This verdict is the latest development in a series of legal challenges involving Johnson & Johnson’s talc products.
Key Facts
- Background of the Case: Theresa Garcia passed away in July 2020 after being diagnosed with mesothelioma, a rare form of cancer often linked to asbestos exposure. Her family filed a lawsuit claiming that Garcia’s regular use of Johnson & Johnson and Kenvue’s talcum-based baby powder contributed to her illness.
- Evidence Presented: The legal firm Dean Omar Branham Shirley, representing the Garcia family, presented evidence showing that the talcum products contained asbestos fibers. Experts testified that the amount Garcia inhaled over her lifetime led to her mesothelioma diagnosis.
- Jury Decision: The jury determined that Kenvue, which became an independent company in August 2023 after separating from Johnson & Johnson, was responsible for 70% of the factors contributing to Garcia’s death. Johnson & Johnson and another subsidiary were deemed responsible for the remaining 30%.
- Company’s Response: Erik Haas, Johnson & Johnson’s Worldwide Vice President of Litigation, announced that the company plans to appeal the Illinois ruling. Haas stated, “The verdict in this trial is irreconcilable with the decades of independent scientific evaluations confirming talc is safe, does not contain asbestos, and does not cause cancer.”
Contrasting Verdicts
The Illinois ruling came a day after a Florida court dismissed a similar lawsuit. In that case, the jury found that Johnson & Johnson’s baby powder did not contribute to the ovarian cancer diagnosis of Patricia Matthey, who died in 2019 after using the product daily for several years.
Key Background
Johnson & Johnson has consistently asserted that its talc-based baby powder is safe and free of asbestos. However, the company decided to replace talc with cornstarch in its products globally, starting in 2023. This decision followed the discontinuation of talc-based products in North America in 2020 due to declining sales and ongoing legal challenges.
In July 2019, the Justice Department launched an investigation into what Johnson & Johnson knew about the cancer risks associated with its talc products. Facing thousands of lawsuits alleging health issues caused by talc, Johnson & Johnson filed for bankruptcy twice, in October 2021 and April 2023. As part of these legal proceedings, the company proposed an $8.9 billion settlement in April 2023 to resolve claims from thousands of plaintiffs, but the plan was rejected by a judge in July.
Future Implications
The recent rulings highlight the ongoing legal battles Johnson & Johnson faces over its talcum powder products. As the company navigates appeals and settlements, the outcomes of these cases will likely impact its financial and reputational standing. The continued scrutiny of talcum products underscores the importance of rigorous safety evaluations and transparent communication with consumers.
